Article Versions Notes

Bocanegra A, Fernandez-Hinojal G, Zuazo-Ibarra M, Arasanz H, Garcia-Granda MJ, Hernandez C, Ibañez M, Hernandez-Marin B, Martinez-Aguillo M, Lecumberri MJ, et al. PD-L1 Expression in Systemic Immune Cell Populations as a Potential Predictive Biomarker of Responses to PD-L1/PD-1 Blockade Therapy in Lung Cancer. International Journal of Molecular Sciences. 2019; 20(7):1631. https://doi.org/10.3390/ijms20071631

Bocanegra, Ana, Gonzalo Fernandez-Hinojal, Miren Zuazo-Ibarra, Hugo Arasanz, Maria Jesus Garcia-Granda, Carlos Hernandez, Maria Ibañez, Berta Hernandez-Marin, Maite Martinez-Aguillo, Maria Jose Lecumberri, and et al. 2019. "PD-L1 Expression in Systemic Immune Cell Populations as a Potential Predictive Biomarker of Responses to PD-L1/PD-1 Blockade Therapy in Lung Cancer" International Journal of Molecular Sciences 20, no. 7: 1631. https://doi.org/10.3390/ijms20071631

Bocanegra, A., Fernandez-Hinojal, G., Zuazo-Ibarra, M., Arasanz, H., Garcia-Granda, M. J., Hernandez, C., Ibañez, M., Hernandez-Marin, B., Martinez-Aguillo, M., Lecumberri, M. J., Fernandez de Lascoiti, A., Teijeira, L., Morilla, I., Vera, R., Escors, D., & Kochan, G. (2019). PD-L1 Expression in Systemic Immune Cell Populations as a Potential Predictive Biomarker of Responses to PD-L1/PD-1 Blockade Therapy in Lung Cancer. International Journal of Molecular Sciences, 20(7), 1631. https://doi.org/10.3390/ijms20071631